New modality types, such as peptides, oligonucleotides, and compound mixtures present new challenges for sample management groups. At Merck site-based Compound Submission Labs (CSLs) are the primary conduit between medicinal chemists and biologists; therefore, it is important for the CSLs to be equipped with appropriate tools and workflows for handling these new modalities. This poster will illustrate new workflows, liquid handling capabilities, and software recently implemented within the CSLs and will highlight the resulting improvement in both project workflows and cycle times.
Born in Colombia, South America. Graduated from Universidad del Valle, Cali, Colombia in 1992. Worked at Schering Plough from 2000-2010 and at Merck since 2010.
